Eun Yang
Stock Analyst at Jefferies
(0)
# 4733
Out of 5,217 analysts
71
Total ratings
41.67%
Success rate
-20.63%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
United Therapeutics | Maintains: Strong Buy | 315 432 | 370.83 | 16.5% | 7 | Sep 23, 2024 | |
Aerovate Therapeutic... | Downgrades: Hold | 65 2 | 2.54 | -21.26% | 3 | Jun 17, 2024 | |
Taysha Gene Therapie... | Assumes: Buy | 2 8 | 2.04 | 292.16% | 2 | May 14, 2024 | |
Deciphera Pharmaceut... | Downgrades: Hold | 26 26 | n/a | n/a | 1 | Apr 29, 2024 | |
Astria Therapeutics | Maintains: Strong Buy | 22 27 | 9.7 | 178.35% | 2 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 2 | 1.03 | 45.63% | 2 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 170 18 | n/a | n/a | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 24 33 | 27.83 | 18.58% | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 36 28 | 5.75 | 386.96% | 2 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 23.58 | 14.5% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 2.64 | 165.15% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 42 | n/a | n/a | 2 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 17 7 | 4.34 | 61.29% | 3 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 2.98 | 738.93% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 525 75 | 1.27 | 5805.51% | 1 | Sep 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 78 84 | 95.55 | -12.09% | 3 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 1.68 | 1388.1% | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 16.28 | 114.99% | 1 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 14 5 | n/a | n/a | 2 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 13 6 | n/a | n/a | 3 | Jan 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 160 | n/a | n/a | 4 | Oct 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 220 | 269.46 | -18.36% | 3 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Jan 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 38 31 | 17.22 | 80.02% | 4 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 26 25 | n/a | n/a | 4 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 400 | 2.15 | 18504.65% | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 310 | 151.03 | 105.26% | 3 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 80 | 92.81 | -13.8% | 3 | Jul 11, 2017 |